Anlotinib Hydrochloride Capsule Clinical Trials
3 recruitingDrug
Phase 21Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 2
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Ji Yongling20 enrolled1 locationNCT06379087
Recruiting
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Neoplasms
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.380 enrolled3 locationsNCT05994365
Recruiting
Phase 4
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Medullary Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.360 enrolled19 locationsNCT05830500